Hemodynamic evaluation before liver transplantation: Insights into the portal hypertensive syndrome

Journal of Clinical Gastroenterology

Volumn 41, Issue SUPPL. 3, 2007, Pages

  Blei, Andres T ^a,c   Mazhar, Sameer ^a   Davidson, Charles J ^b   Flamm, Steven L ^a   Abecassis, Michael ^c   Gheorghiade, Mihai ^b  

^a Division of Hepatology   (United States)

^b Department of Medicine   (Taiwan)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cardiac failuref; Coronary atherosclerosis; Liver transplantation; Portal hypertension

Indexed keywords

ADULT; AGED; ATHEROSCLEROSIS; CARDIOPULMONARY HEMODYNAMICS; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE SEVERITY; FEMALE; HEART HEMODYNAMICS; HIGH OUTPUT HEART FAILURE; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PORTAL HYPERTENSION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

AGED; CARDIAC OUTPUT; CATHETERIZATION, SWAN-GANZ; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; HYPERTENSION, PORTAL; HYPERTENSION, PULMONARY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SYNDROME; VASCULAR RESISTANCE; VENTRICULAR FUNCTION, LEFT;

EID: 35848969506     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318157188e     Document Type: Conference Paper

References (57)

1. Cardenas A, Gines P. Management of complications of cirrhosis in patients awaiting liver transplantation. J Hepatol. 2005;42 (suppl):S124-S133. [Epub December 24, 2004].
2. Flamm S, Kulik L, Blei AT. Managing the complications of cirrhosis on the transplant waiting list. In: Arroyo V, Navasa M, Forns X, et al, eds. Update in Treatment of Liver Disease. Barcelona: Ars Medica; 2005:367-375.
3. Klupp J, Kohler S, Pascher A, et al. Liver transplantation as ultimate tool to treat portal hypertension. Dig Dis. 2005;23:65-71.
4. Davidson CJ, Gheorghiade M, Flaherty JD, et al. Predictive value of stress myocardial perfusion imaging in liver transplant candidates. Am J Cardiol. 2002;89:359-360.
5. Tiukinhoy-Laing SD, Rossi JS, Bayram M, et al. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardiol. 2006;98:178-181. [Epub May 12, 2006].
6. Tucker ON, Heaton N. The "small for size" liver syndrome. Curr Opinion Crit Care. 2005;11:150-155.
7. Lee SS, Hadengue A, Girod C, et al. Reduction of intrahepatic vascular space in the pathogenesis of portal hypertension. In vitro and in vivo studies in the rat. Gastroenterology. 1987;93:157-161.
8. Groszmann RJ. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology. 1994;20:1359-1363.
9. Man K, Fan ST, Lo CM, et al. Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression. Ann Surg. 2003;237:256-264.
10. Salvalaggio PR, Baker TB, Koffron AJ, et al. Liver graft volume estimation in 100 living donors: measure twice, cut once. Transplantation. 2005;80:1181-1185.
11. Troisi R, de Hemptinne B. Clinical relevance of adapting portal vein flow in living donor liver transplantation in adult patients. Liver Transplantation. 2003;9:S36-S41.
12. Luca A, Miraglia R, Caruso S, et al. Effects of splenic artery occlusion on portal pressure in patients with cirrhosis and portal hypertension. Liver Transplantation. 2006;12:1237-1243.
13. Zetterman RK, Belle SH, Hoofnagle JH, et al. Age and liver transplantation: a report of the Liver Transplantation Database. Transplantation. 1998;66:500-506.
14. Lyon CJ, Law RE, Hsueh WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology. 2003;144:2195-2200.
15. Powell EE, Jonsson JR, Clouston AD. Steatosis: co-factor in other liver diseases. Hepatology. 2005;42:5-13.
16. Guevara M, Fernández-Esparrach G, Alessandria C, et al. Effects of contrast media on renal function in patients with cirrhosis: a prospective study. Hepatology. 2004;40:646-651.
17. Therapondos G, Flapan AD, Plevris JN, et al. Cardiac morbidity and mortality related to orthotopic liver transplantation. Liver Transplantation. 2004;10:1441-1453.
18. Donovan CL, Marcovitz PA, Punch JD, et al. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation. 1996;61:1180-1188.
19. Caldwell SH, Oelsner DH, Iezzoni JC, et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999;29:664-669.
20. Bosch J, Abraldes JG, Groszmann R. Current management of portal hypertension. J Hepatol. 2003;38(suppl 1):S54-S68.
21. Perkins J. Left ventricular dysfunction: a hidden risk in patients undergoing liver transplantation. Liver Transplantation. 2007;13:165-166.
22. Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology. 2006;43(2 suppl 1):S121-S131.
23. Braillon A, Cales P, Valla D, et al. Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis. Gut. 1986;27:1204-1209.
24. Wiest R, Das S, Cadelina G, et al. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J Clin Invest. 1999;104:1223-1233.
25. Cirera I, Bauer TM, Navasa M, et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol. 2001;34:32-37.
26. Sikuler E, Kravetz D, Groszmann RJ. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol. 1985;248:G618-G625.
27. Lebrec D, Bataille C, Bercoff E, et al. Hemodynamic changes in patients with portal venous obstruction. Hepatology. 1983;3:550-553.
28. Grant WC, Wasserman F, Rodensky PL, et al. The incidence of myocardial infarction in portal cirrhosis. Ann Intern Med. 1959;51:774-779.
29. Vanecek R. Atherosclerosis and cirrhosis if the liver. Bull World Health Org. 1976;53:567-570.
30. Gaziano JM, Buring JE, Breslow JL, et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 1993;329:1829-1834.
31. Keeffe BG, Valantine H, Keeffe EB. Detection and treatment of coronary artery disease in liver transplant candidates. Liver Transplantation. 2001;7:755-761.
32. Burke A, Lucey M. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transplant. 2004;4:686-693.
33. Targher G, Bertolini L, Padovani R, et al. Differences and similarities in early atherosclerosis between patients with nonalcoholic steatohepatitis and chronic hepatitis B and C. J Hepatol. 2007;46:1126-1132. [Epub February 15, 2007].
34. Gonzalez MA, Selwyn AP. Endothelial function, inflammation, and prognosis in cardiovascular disease. Am J Med. 2003;115(suppl 8A):99S-106S.
35. Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev. 2006;22:423-436.
36. Widlansky ME, Gokce N, Keaney JF, et al. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42:1149-1160.
37. Polio J, Groszmann RJ, Reuben A, et al. Portal hypertension ameliorates arterial hypertension in spontaneously hypertensive rats. J Hepatol. 1989;8:294-301.
38. Félétou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder. Am J Physiol Heart Circ Physiol. 2006;291:H985-H1002.
39. Villanova N, Moscatiello S, Ramilli S, et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology. 2005;42:473-480.
40. Gheorghiade M, Zannad F, Sopko G, et al. Acute heart failure syndromes: current state and framework for future research. Circulation. 2005;112:3958-3968.
41. Lee RF, Glenn TK, Lee SS. Cardiac dysfunction in cirrhosis. Best Pract Res Clin Gastroenterol. 2007;21:125-140.
42. Myers RP, Lee SS. Cirrhotic cardiomyopathy and liver transplantation. Liver Transplantation. 2000;6(4 suppl 1):S44-S52.
43. Ruiz-del-Arbol L, Monescillo A, Arocena C, et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology. 2005;42:439-447.
44. Moller S, Henriksen JH. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart. 2002;87:9-15.
45. Lévy S, Hervé C, Delacoux E, et al. Thiamine deficiency in hepatitis C virus and alcohol-related liver diseases. Dig Dis Sci. 2002;47:543-548.
46. Machackova J, Barta J, Dhalla NS. Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies. Can J Cardiol. 2006;22:953-968.
47. Colle IO, Moreau R, Godinho E, et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology. 2003;37:401-409.
48. Krowka MJ, Swanson KL, Frantz RP, et al. Portopulmonary hypertension: results from a 10-year screening algorithm. Hepatology. 2006;44:1502-1510.
49. Passarella M, Fallon MB, Kawut SM. Portopulmonary hypertension. Clin Liver Dis. 2006;10:653-663.
50. Henderson JM, Mackay GJ, Hooks M, et al. High cardiac output of advanced liver disease persists after orthotopic liver transplantation. Hepatology. 1992;15:258-262.
51. Hadengue A, Lebrec D, Moreau R, et al. Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients. Hepatology. 1993;17:175-178.
52. Navasa M, Feu F, García-Pagán JC, et al. Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology. 1993;17:355-360.
53. Textor SC, Wiesner R, Wilson DJ, et al. Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients. Transplantation. 1993;55:1332-1339.
54. Piscaglia F, Zironi G, Gaiani S, et al. Systemic and splanchnic hemodynamic changes after liver trans-plantation for cirrhosis: a long-term prospective study. Hepatology. 1999;30:58-64.
55. Torregrosa M, Aguadé S, Dos L, et al. Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol. 2005;42:68-74.
56. Johnston SD, Morris JK, Cramb R, et al. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation. 2002;73:901-906.
57. Guckelberger O, Mutzke F, Glanemann M, et al. Validation of cardiovascular risk scores in a liver transplant population. Liver Transplantation. 2006;12:394-401.